The Cannabinoid CB1 Receptor in Schizophrenia - Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Endocannabinoid signalling and the deteriorating brain | Nature Reviews Neuroscience
The endocannabinoid system and its therapeutic exploitation | Nature Reviews Drug Discovery
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity | Neuropsychopharmacology
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science
IJMS | Free Full-Text | Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Frontiers | Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development | Neuropsychopharmacology
Crystal Structure of the Human Cannabinoid Receptor CB1: Cell
Frontiers | Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease
IJMS | Free Full-Text | Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
Pharmaceutics | Free Full-Text | “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system | PLOS ONE
Exploring CB1, CB2 in Various Neurological Conditions
High-resolution crystal structure of the human CB1 cannabinoid receptor | Nature
IJMS | Free Full-Text | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination | eLife
mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability - ScienceDirect
Frontiers | Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Cannabinoid CB1 and CB2 Receptor Signaling and Bias | Cannabis and Cannabinoid Research
Cannabinoid receptor type-1: breaking the dogmas | F1000Research
IJMS | Free Full-Text | New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
